Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD
The FDA has granted Fast Track designation to Zimura (avacincaptad pegol; Iveric Bio) for the treatment of geographic atrophy secondary to dry age-related macular degeneration.